1. Home
  2. MXCT vs HYNE Comparison

MXCT vs HYNE Comparison

Compare MXCT & HYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$1.18

Market Cap

129.6M

Sector

Health Care

ML Signal

HOLD

HYNE

Hoyne Bancorp Inc.

N/A

Current Price

$16.28

Market Cap

116.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
MXCT
HYNE
Founded
1999
2025
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
129.6M
116.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
MXCT
HYNE
Price
$1.18
$16.28
Analyst Decision
Buy
Analyst Count
4
0
Target Price
$5.50
N/A
AVG Volume (30 Days)
1.3M
21.2K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$33,026,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$18.50
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$13.56
52 Week High
$2.38
$16.33

Technical Indicators

Market Signals
Indicator
MXCT
HYNE
Relative Strength Index (RSI) 64.09 71.04
Support Level $0.77 $15.51
Resistance Level $1.82 N/A
Average True Range (ATR) 0.09 0.16
MACD 0.01 0.05
Stochastic Oscillator 60.00 95.62

Price Performance

Historical Comparison
MXCT
HYNE

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

About HYNE Hoyne Bancorp Inc.

Hoyne Bancorp Inc is a holding company that conducts business mainly through its subsidiaries. It is a savings institution focused on serving customers' banking needs in the market area. The group offers Personal and Business banking services.

Share on Social Networks: